JPM Thematics - Genetic Therapies C2 Fonds
77,07
EUR
+1,62
EUR
+2,15
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Bristol-Myers Squibb Co | US1101221083 | 3,60% |
| Gilead Sciences Inc | US3755581036 | 3,55% |
| Amgen Inc | US0311621009 | 3,53% |
| Novartis AG Registered Shares | CH0012005267 | 3,52% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,40% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,33% |
| Krystal Biotech Inc | US5011471027 | 3,32% |
| Lonza Group Ltd | CH0013841017 | 3,32% |
| Takeda Pharmaceutical Co Ltd | JP3463000004 | 3,20% |
| PTC Therapeutics Inc | US69366J2006 | 3,14% |
| Sonstige | 66,09% |